Danaher Corp
Close on Nov 2, 2026Market cap $160.26BP/E 40.5Yield –
Danaher Life Sciences — Core Sales Growth by Year
Life Sciences — Core Sales Growth (%) (%)
Danaher Life Sciences — Core Sales Growth: -1.5% in FY2025, up 0.5 pts from a year earlier.
Where the FY2025 figure comes from
Source: Danaher IR — nongaap_2025Q4 ↗
Includes SCIEX, Beckman Coulter Life Sciences, Leica Microsystems, Molecular Devices, Phenomenex, IDT, Aldevron, and Abcam.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Life Sciences — Core Sales Growth (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | -1.5% | +0.5 pts | Danaher IR — nongaap_2025Q4 ↗ |
| FY2024 | Dec 31, 2024 | -2.0% | -3.0 pts | Danaher IR — nongaap_2024Q4 ↗ |
| FY2023 | Dec 31, 2023 | 1.0% | -8.5 pts | Danaher IR — nongaap_2023Q4 ↗ |
| FY2022 | Dec 31, 2022 | 9.5% | – | Danaher IR — nongaap_ex_veralto ↗ |
Breakdown
What makes up life Sciences — Core Sales Growth
Cite this data
StockData. (2026). Danaher Life Sciences — Core Sales Growth (%), annual FY2022–FY2025 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/core-sales-growth-lifesci
See every metric in the Danaher KPI table. Data updated Nov 2, 2026.